发明名称 |
ORAL PHARMACEUTICAL COMPOSITION |
摘要 |
<p>The present invention provides an FTD and TPI-containing oral pharmaceutical composition which can be orally administered and is stable even under high humidity conditions. An oral pharmaceutical composition comprising ±,±,±-trifluorothymidine and 5-chloro-6-(2-iminopyrrolidine-1-yl)methyl-2,4(1H,3H)-pyrimidine dione hydrochloride as an active ingredient; and being substantially free of an additive comprising a metal salt.</p> |
申请公布号 |
SG11201403875V(A) |
申请公布日期 |
2014.10.30 |
申请号 |
SG11201403875V |
申请日期 |
2013.02.14 |
申请人 |
TAIHO PHARMACEUTICAL CO., LTD. |
发明人 |
OHNISHI, YOSHITO;OGATA, TETSUO |
分类号 |
A61K31/7068;A61K9/14;A61K9/20;A61K9/30;A61K31/513;A61K47/10;A61K47/12;A61K47/26;A61K47/32;A61K47/36;A61K47/38;A61K47/44;A61P35/00;A61P43/00 |
主分类号 |
A61K31/7068 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|